Here are the key things you need to know about in the NZX markets over the past 24 hours. Changes are as at 3:00 pm and may change when the market closes at 4:45 pm.
WHAT THE NZX 50 INDEX IS DOING
The index is set to gain +0.2% today, down -0.5% over the past five days. Year-on-year it has grown +4.9%.
THE MAIN GAINERS
There were 40 gainers today led by a2 Milk (ATM, #7) who gained +3%. Over the past five days a2 Milk has gained +3%, up a strong +58% year-on-year. F&P Healthcare (FPH, #1) gained +2%, up +5% month-on-month. Year-on-year the company's share price has advanced +13%. Briscoe Group (BGP, #30) also gained +2%, declining by -17% over the last six months. Year-on-year it has gained +8%. Vista Group (VGL, #46) is up +2%, down -9% month-on-month. From this time last year Vista has declined by a heavy -43%.
A2 Milk
Select chart tabs
THE MAIN DECLINERS
There were also 40 decliners with the biggest drop by SkyCity Entertainment (SKC, #33) who declined by -3%. Over the past five days its share price has declined by -6%, falling -31% year-on-year. Kiwi Property Group (KPG, #22) and EBOS Group (EBO, #10) both declined -2%. Kiwi Property Group has declined by -7% month-on-month, gaining +8% year-on-year. EBOS Group has declined by -7% month-on-month, down -36% year-on-year. Followed by Summerset Group Holdings (SUM, #17) down -1%, declining -12% on an annual basis.
SKYCITY Entertainment
Select chart tabs
SMARTSHARES EFTs
| 1-day | 5-day | 6-month | YTD | 1Y | |
| NZ Top 50 ETF (FNZ) | +0.03% | -0.7% | +5.0% | -2.1% | +3.3% |
| NZ Top 10 ETF (TNZ) | +0.8% | +0.4% | +3.5% | -0.2% | -2.1% |
| S/P NZX50 ETF (NZG) | +0.8% | -0.3% | +4.9% | -0.3% | +2.1% |
| NZ Dividend ETF (DIV) | -0.6% | -1.2% | +7.9% | -1.2% | +10.8% |
KEY ANNOUNCEMENTS
Briscoe Group (BGP, #30) reported record Q4 sales of $256.6mln, up +4.6%, with homeware up +3.5% and sporting goods up +6.5%. Full‑year sales reached a record $798.8mln, up +0.9%. Online sales made up 20% of total sales. The full‑year gross margin is expected to be about 39.2%, and inventory will finish at least $5mln lower than last year. Full‑year NPAT is expected to be $59m-$60mln. Full results will be released on the 11th of March.
Ryman Healthcare (RYM, #16) has outlined a refreshed strategy aimed at improving cash flow and strengthening long‑term returns. The company is targeting $150mln in sustainable cash‑flow improvement by FY29 and expects to release $500mln in cash by FY29, including at least $200mln from land sales. Ryman plans to grow recurring earnings from its existing portfolio and has identified 2,500 potential units and beds for future development. A new capital management framework has been introduced, with the company aiming to resume sustainable dividends in FY28. FY26 guidance is unchanged.
NZX50 Healthcare Sector
Select chart tabs
Click on the chart title to find more about this sector, including its components.
We welcome your comments below. If you are not already registered, please register to comment
Remember we welcome robust, respectful and insightful debate. We don't welcome abusive or defamatory comments and will de-register those repeatedly making such comments. Our current comment policy is here.